Medical equipment maker Perfint Healthcare, on Thursday, announced that it had secured $11 million of ‘Series D’ funding from Norwest Venture Partners for expansion and commercialisation of its new products.

The Chennai-based firm recently launched its robotic targeting system for CT-guided tumor ablations in India and the Asia-Pacific and is awaiting regulatory approval for the American, Chinese and Japanese markets.

“Besides commercialisation of our new product Maxio, the money will go towards the setting up and expansion of our advanced technology lab in the U.S. and new product development,” said S Nandakumar, CEO, Perfint Healthcare.

“While the investors will be with us for the long-run, some of them may look at exit through an initial public offer or a strategic sale,” he added.

More In: Companies | Business